TOP TIERMARKET NEWSWIRE
News & sentiment

STIFEL FINL CORP (SF) — News & AI sentiment

STIFEL FINL CORP (SF) news roundup. 2 stories in the last 24 hours, 53 in the past week, 170 over 30 days. Average 24-hour sentiment is 56.5/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $372K — net selling of $372K. US House Periodic Transaction Reports (90-day window): 3 purchases (~$24K) and 0 sales (~$0). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
2
avg sentiment 56.5/100
7d stories
53
avg sentiment 56.4/100
30d stories
170
avg sentiment 56.9/100
Insider net (90d)
$372K
0 buys · 1 sells
Congress (90d)
3
3 buys · 0 sells

SF news in the last 24 hours, 7 days, 30 days and 90 days

How much SF coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowSF storiesAvg AI sentimentRead
Last 24 hours256.5/100SF headlines →
Last 7 days5356.4/100SF headlines →
Last 30 days17056.9/100SF headlines →
Last 90 days31056.7/100SF headlines →

Latest stories on SF

17h ago
1d ago
KBW Announces Index Rebalancing for Third-Quarter 2026
Business Insider50 · neutralgeneral
1d ago
Stifel reiterates Salesforce stock Buy rating on revenue growth
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
Stifel reiterates Taiwan Semi stock rating on strong August sales
Investing.com Analyst Ratings56 · neutralanalyst
2d ago
2d ago
Stifel raises Inspire Medical stock price target on reimbursement outlook
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
2d ago
Stifel sees CMS TAVR coverage update as positive for Edwards
Investing.com Markets63 · neutralanalyst
2d ago
3d ago
3d ago
Stifel reiterates Immunic stock rating on MS drug potential
Investing.com Analyst Ratings56 · neutralanalyst
3d ago
Stifel reiterates Biogen stock rating on immunology pipeline
Investing.com Analyst Ratings56 · neutralanalyst
3d ago
Stifel reiterates Buy on Monolithic Power stock on capacity growth
Investing.com Analyst Ratings61 · neutralanalyst
3d ago
3d ago
Stifel reiterates Buy rating on Klaviyo stock, $22 target
Investing.com Analyst Ratings61 · neutralanalyst
3d ago
Occidental resumed with a Hold at Stifel
The Fly50 · neutralanalyst
4d ago
4d ago
4d ago
4d ago
4d ago
4d ago
4d ago
4d ago
4d ago
Open SF in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →